Cargando…
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
Despite recent advances in therapy, liver metastasis from melanoma is still associated with poor prognosis. Although targeting the mTOR signaling pathway exerts potent anti-tumor activity, little is known about specific mTORC2 inhibition regarding liver metastasis. Using the novel mTORC2 specific in...
Autores principales: | Guenzle, Jessica, Akasaka, Harue, Joechle, Katharina, Reichardt, Wilfried, Venkatasamy, Aina, Hoeppner, Jens, Hellerbrand, Claus, Fichtner-Feigl, Stefan, Lang, Sven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792954/ https://www.ncbi.nlm.nih.gov/pubmed/33375117 http://dx.doi.org/10.3390/ijms22010030 |
Ejemplares similares
-
Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases
por: Joechle, Katharina, et al.
Publicado: (2022) -
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis()()
por: Schmidt, Katharina M., et al.
Publicado: (2018) -
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
por: Joechle, Katharina, et al.
Publicado: (2021) -
Ogilvie’s syndrome—is there a cutoff diameter to proceed with upfront surgery?
por: Joechle, Katharina, et al.
Publicado: (2022) -
Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
por: Schmidt, Katharina M., et al.
Publicado: (2017)